← back

The whale feed

Who just crossed 5%?

When anyone — family offices, activist funds, sovereign wealth, famous CEOs buying into other companies — crosses a 3–5% voting- rights threshold in an EU or UK listed company, they must disclose it within 2–4 trading days. A different signal from Article 19 PDMR filings — conviction across the table, not inside one.

Filtered byKuros Biosciences Ltd.×Clear all
Buy Kuros Biosciences Ltd.
Pick a broker. We handle the signal, they handle execution.

Affiliate links — we may earn a referral fee if you sign up.

Matching filings

Showing 13 most recent
FiledFilerCompanyMoveNew %Source
2025-10-30
6mo ago
🇨🇭Universal-Investment-Gesellschaft mit beschränkter HaftungKuros Biosciences Ltd.$CYTOS↓ crossed below3.00%regulator →
2025-07-12
10mo ago
🇨🇭Universal-Investment-Gesellschaft mit beschränkter HaftungKuros Biosciences Ltd.$CYTOS↑ crossed above3.06%regulator →
2025-06-25
11mo ago
🇨🇭Chris OomenKuros Biosciences Ltd.$CYTOS↑ crossed above24.83%regulator →
2025-06-24
11mo ago
🇨🇭Chris OomenKuros Biosciences Ltd.$CYTOSdisclosedregulator →
2025-05-24
12mo ago
🇨🇭Alpha Capital AGKuros Biosciences Ltd.$CYTOS↑ crossed above4.81%regulator →
2025-05-24
12mo ago
🇨🇭Alpha Capital AGKuros Biosciences Ltd.$CYTOS↓ crossed below3.00%regulator →
2025-05-24
12mo ago
🇨🇭Alpha Capital AGKuros Biosciences Ltd.$CYTOS↓ crossed below3.00%regulator →
2025-05-24
12mo ago
🇨🇭Alpha Capital AGKuros Biosciences Ltd.$CYTOS↑ crossed above5.43%regulator →
2025-05-24
12mo ago
🇨🇭Alpha Capital AGKuros Biosciences Ltd.$CYTOS↑ crossed above4.87%regulator →
2025-05-24
12mo ago
🇨🇭Alpha Capital AGKuros Biosciences Ltd.$CYTOS↑ crossed above4.20%regulator →
2025-05-24
12mo ago
🇨🇭Alpha Capital AGKuros Biosciences Ltd.$CYTOS↑ crossed above5.91%regulator →
2025-05-23
12mo ago
🇨🇭Alpha Capital AGKuros Biosciences Ltd.$CYTOS↓ crossed below3.00%regulator →
2025-05-23
12mo ago
🇨🇭Alpha Capital AGKuros Biosciences Ltd.$CYTOS↑ crossed above9.94%regulator →

Why this signal matters

A CEO buying €1m of their own stock is confidence. A family office quietly accumulating 5% of a small listed industrial is conviction across the table — and often a leading indicator of an activist campaign, a take-private bid, a sovereign wealth allocation, or a cornerstone investment. Academic literature (Brav, Jiang, Kim 2010 on activism; Bebchuk et al 2013) consistently finds substantial outperformance in the months following 13D / equivalent filings in the US. Europe's Transparency Directive is the European equivalent.